200 related articles for article (PubMed ID: 2501022)
21. Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action.
Rutanen EM; Pekonen F; Mäkinen T
J Clin Endocrinol Metab; 1988 Jan; 66(1):173-80. PubMed ID: 2961785
[TBL] [Abstract][Full Text] [Related]
22. Characterization and regulation of a specific cell membrane receptor for somatomedin-C/insulin-like growth factor I in cultured rat granulosa cells.
Adashi EY; Resnick CE; Hernandez ER; Svoboda ME; Van Wyk JJ
Endocrinology; 1988 Jan; 122(1):194-201. PubMed ID: 2961555
[TBL] [Abstract][Full Text] [Related]
23. Characterization of somatomedin/insulin-like growth factor receptors and correlation with biologic action in cultured neonatal rat astroglial cells.
Han VK; Lauder JM; D'Ercole AJ
J Neurosci; 1987 Feb; 7(2):501-11. PubMed ID: 2950212
[TBL] [Abstract][Full Text] [Related]
24. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
[TBL] [Abstract][Full Text] [Related]
25. Fetal rat myoblasts release both rat somatomedin-C (SM-C)/insulin-like growth factor I (IGF I) and multiplication-stimulating activity in vitro: partial characterization and biological activity of myoblast-derived SM-C/IGF I.
Hill DJ; Crace CJ; Nissley SP; Morrell D; Holder AT; Milner RD
Endocrinology; 1985 Nov; 117(5):2061-72. PubMed ID: 4042975
[TBL] [Abstract][Full Text] [Related]
26. Role of insulin-like growth factor-related peptides in the estradiol-, prolactin-, and progesterone-stimulated growth of N-nitrosomethylurea-induced rat mammary tumors in soft agar.
Manni A; Wright C; Badger B; Lynch J; Demers L
Cancer Res; 1990 Nov; 50(22):7179-83. PubMed ID: 2224853
[TBL] [Abstract][Full Text] [Related]
27. Further characterization of human basic-somatomedin: comparison with insulin-like growth factors I and II.
Bhaumick B; Goren HJ; Bala RM
Horm Metab Res; 1981 Sep; 13(9):515-8. PubMed ID: 6271660
[TBL] [Abstract][Full Text] [Related]
28. The effects of altered nutritional status upon insulin-like growth factors and their binding proteins in neonatal rats.
Philipps A; Drakenberg K; Persson B; Sjögren B; Eklöf AC; Hall K; Sara V
Pediatr Res; 1989 Aug; 26(2):128-34. PubMed ID: 2475850
[TBL] [Abstract][Full Text] [Related]
29. Response of mammary tumors to caloric restriction for different time periods during the promotion phase.
Kritchevsky D; Welch CB; Klurfeld DM
Nutr Cancer; 1989; 12(3):259-69. PubMed ID: 2505241
[TBL] [Abstract][Full Text] [Related]
30. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.
Kledzik GS; Bradley CJ; Marshall S; Campbell GA; Meites J
Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050
[TBL] [Abstract][Full Text] [Related]
31. Influence of hormonal alteration of host on estrogen-binding capacity in 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
Gibson SL; Hilf R
Cancer Res; 1976 Oct; 36(10):3736-41. PubMed ID: 133755
[TBL] [Abstract][Full Text] [Related]
32. Ontogeny and characterization of basic somatomedin receptors in rat placenta.
Bhaumick B; Bala RM
Endocrinology; 1985 Feb; 116(2):492-8. PubMed ID: 2981662
[TBL] [Abstract][Full Text] [Related]
33. Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumors.
Dogan S; Johannsen AC; Grande JP; Cleary MP
Nutr Cancer; 2011; 63(3):389-401. PubMed ID: 21462085
[TBL] [Abstract][Full Text] [Related]
34. Expression of angiogenic factors is upregulated in DMBA-induced rat mammary pathologies.
Yan M; Schneider J; Gear R; Lu F; LaDow K; Warshawsky D; Heffelfinger SC
Pathobiology; 2004; 71(5):253-60. PubMed ID: 15459484
[TBL] [Abstract][Full Text] [Related]
35. Prolactin receptors in 7,12-dimethylbenz(a) anthracene-induced mammary tumors following endocrine ablation.
Costlow ME; Buschow RA; McGuire WL
Cancer Res; 1976 Nov; 36(11 Pt 1):3941-3. PubMed ID: 184919
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of L-arginine on growth of rat mammary tumors induced by 7,12-dimethylbenz(a)anthracene.
Takeda Y; Tominaga T; Tei N; Kitamura M; Taga S
Cancer Res; 1975 Sep; 35(9):2390-3. PubMed ID: 807324
[TBL] [Abstract][Full Text] [Related]
37. Life span extension by reduction of the growth hormone-insulin-like growth factor-1 axis: relation to caloric restriction.
Shimokawa I; Higami Y; Tsuchiya T; Otani H; Komatsu T; Chiba T; Yamaza H
FASEB J; 2003 Jun; 17(9):1108-9. PubMed ID: 12692087
[TBL] [Abstract][Full Text] [Related]
38. Effect of endurance exercise on somatomedin-C/insulin-like growth factor I concentration in male and female runners.
Jahreis G; Hesse V; Schmidt HE; Scheibe J
Exp Clin Endocrinol; 1989 Sep; 94(1-2):89-96. PubMed ID: 2599025
[TBL] [Abstract][Full Text] [Related]
39. Characterization of insulin-like growth factor I receptors in the median eminence of the brain and their modulation by food restriction.
Bohannon NJ; Corp ES; Wilcox BJ; Figlewicz DP; Dorsa DM; Baskin DG
Endocrinology; 1988 May; 122(5):1940-7. PubMed ID: 2966061
[TBL] [Abstract][Full Text] [Related]
40. Biochemical alterations in 7,12-dimethylbenz[a]anthracene-induced mammary tumors from rats subjected to caloric restriction.
Ruggeri BA; Klurfeld DM; Kritchevsky D
Biochim Biophys Acta; 1987 Jul; 929(3):239-46. PubMed ID: 3038194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
